The potential of adding mammography to HHUS and ABUS to reduce unnecessary biopsies in  BI-RADS ultrasound category 4a: a multicenter hospital-based study in China

Author:

Ren Wenhui1,Zhao Xuelian2,Zhao Xiaowei2,Yan Huijiao3,Hu Shangying2,Qiao Youlin3,Xu Zhijian2,Zhao Fanghui2ORCID

Affiliation:

1. National Cancer Center/ National Clinical Reasearch Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

2. National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

3. School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College

Abstract

Abstract Purpose This study compares image features influencing false-positive lesions in category 4a between handheld ultrasound (HHUS) and automated breast ultrasound (ABUS) and explores the role of second-look mammography (MAM) adjunct to US of 4a masses. Methods Women aged 30 to 69 underwent HHUS and ABUS from 2016 through 2017 at five high-level hospitals in China with those aged 40 or older also accepting MAM. Logistic regression analysis assessed image variables correlated with false-positive lesions in US category 4a. Unnecessary biopsies, invasive cancer (IC) yields, and diagnostic performance among different biopsy thresholds were compared. Results 1946 women (44.9±9.8 years) were eligible for analysis. 188 (9.66%) were categorized as category 4a in HHUS and 117 (6.01%) of ABUS. Orientation, architectural distortion, and duct change were independent factors associated with the false-positive lesions in 4a of HHUS, whereas premenopausal, size, calcification, and architectural distortion were significant features of ABUS (all P<0.05). For HHUS, both unnecessary biopsy rate and IC yields were significantly reduced when changing biopsy thresholds by adding MAM for US 4a patients (scenario #1:BI-RADS 3, 4, and 5; scenario #2: BI-RADS 4 and 5) compared with the current scenario (all P<0.05). However, scenario #1 reduced false-positive biopsies without affecting IC yields when compared to the current scenario for ABUS (P<0.001; P=0.125). Conclusions The higher unnecessary biopsy rate of category 4a by ABUS was similar to HHUS. However, the second-look MAM adjunct to ABUS has the potential to safely reduce false-positive biopsies.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3